Guardian Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227K | Sell |
9,417
-1,593
| -14% | -$41.7K | 0.15% | 59 |
|
|
2026
Q1 | $309K | Sell |
11,010
-350
| -3% | -$9.32K | 0.24% | 55 |
|
|
2025
Q4 | $283K | Sell |
11,360
-2,950
| -21% | -$74.4K | 0.22% | 56 |
|
|
2025
Q3 | $365K | Buy |
14,310
+558
| +4% | +$13.8K | 0.31% | 53 |
|
|
2025
Q2 | $333K | Buy |
13,752
+2,000
| +17% | +$46.6K | 0.34% | 49 |
|
|
2025
Q1 | $294K | Sell |
11,752
-4,790
| -29% | -$125K | 0.25% | 55 |
|
|
2024
Q4 | $436K | Sell |
16,542
-3,810
| -19% | -$103K | 0.31% | 53 |
|
|
2024
Q3 | $589K | Sell |
20,352
-2,250
| -10% | -$65.6K | 0.51% | 45 |
|
|
2024
Q2 | $632K | Sell |
22,602
-5,098
| -18% | -$140K | 0.45% | 47 |
|
|
2024
Q1 | $769K | Sell |
27,700
-24,700
| -47% | -$685K | 0.62% | 43 |
|
|
2023
Q4 | $1.51M | Sell |
52,400
-7,005
| -12% | -$212K | 1.27% | 24 |
|
|
2023
Q3 | $1.97M | Sell |
59,405
-1,500
| -2% | -$53K | 1.79% | 19 |
|
|
2023
Q2 | $2.23M | Sell |
60,905
-20,606
| -25% | -$802K | 1.9% | 19 |
|
|
2023
Q1 | $2.95M | Buy |
81,511
+18,481
| +29% | +$798K | 2.21% | 17 |
|
|
2022
Q4 | $3.23M | Hold |
63,030
| – | – | 3.05% | 8 |
|
|
2022
Q3 | $2.76M | Sell |
63,030
-11,400
| -15% | -$554K | 2.8% | 10 |
|
|
2022
Q2 | $3.95M | Buy |
74,430
+50
| +0.1% | +$2.55K | 3.44% | 6 |
|
|
2022
Q1 | $3.85M | Sell |
74,380
-2,050
| -3% | -$106K | 2.99% | 7 |
|
|
2021
Q4 | $4.51M | Buy |
76,430
+400
| +0.5% | +$19.8K | 3.14% | 7 |
|
|
2021
Q3 | $3.27M | Sell |
76,030
-5,635
| -7% | -$250K | 2.41% | 12 |
|
|
2021
Q2 | $3.2M | Buy |
81,665
+154
| +0.2% | +$5.99K | 2.19% | 18 |
|
|
2021
Q1 | $2.95M | Buy |
81,511
+6,500
| +9% | +$231K | 2.1% | 19 |
|
|
2020
Q4 | $2.76M | Sell |
75,011
-2,575
| -3% | -$94.5K | 2.09% | 19 |
|
|
2020
Q3 | $2.7M | Buy |
77,586
+527
| +0.7% | +$18.5K | 2.35% | 16 |
|
|
2020
Q2 | $2.39M | Buy |
77,059
+1,845
| +2% | +$62.7K | 2.17% | 16 |
|
|
2020
Q1 | $2.33M | Buy |
75,214
+9,011
| +14% | +$307K | 2.39% | 15 |
|
|
2019
Q4 | $2.46M | Buy |
66,203
+3,373
| +5% | +$120K | 1.96% | 20 |
|
|
2019
Q3 | $2.14M | Buy |
62,830
+270
| +0.4% | +$9.82K | 1.9% | 20 |
|
|
2019
Q2 | $2.57M | Buy |
62,560
+61
| +0.1% | +$2.42K | 2.24% | 14 |
|
|
2019
Q1 | $2.52M | Sell |
62,499
-5,375
| -8% | -$215K | 2.18% | 17 |
|
|
2018
Q4 | $2.81M | Sell |
67,874
-738
| -1% | -$30.6K | 2.6% | 15 |
|
|
2018
Q3 | $2.87M | Buy |
68,612
+1,860
| +3% | +$71.6K | 2.52% | 14 |
|
|
2018
Q2 | $2.3M | Buy |
66,752
+4,559
| +7% | +$156K | 2.2% | 16 |
|
|
2018
Q1 | $2.09M | Hold |
62,193
| – | – | 2.23% | 19 |
|
|
2017
Q4 | $2.14M | Buy |
62,193
+1,691
| +3% | +$57.7K | 2.26% | 18 |
|
|
2017
Q3 | $2.05M | Hold |
60,502
| – | – | 2.26% | 18 |
|
|
2017
Q2 | $1.93M | Sell |
60,502
-5,280
| -8% | -$167K | 2.13% | 19 |
|
|
2017
Q1 | $2.13M | Sell |
65,782
-2,098
| -3% | -$66.1K | 2.32% | 15 |
|
|
2016
Q4 | $2.09M | Buy |
67,880
+6,412
| +10% | +$196K | 2.41% | 15 |
|
|
2016
Q3 | $2.05M | Hold |
61,468
| – | – | 2.28% | 14 |
|
|
2016
Q2 | $2.05M | Sell |
61,468
-5,684
| -8% | -$181K | 2.28% | 14 |
|
|
2016
Q1 | $1.89M | Sell |
67,152
-1,523
| -2% | -$43.5K | 2.16% | 16 |
|
|
2015
Q4 | $2.1M | Sell |
68,675
-2,103
| -3% | -$66.2K | 2.26% | 15 |
|
|
2015
Q3 | $2.14M | Sell |
70,778
-894
| -1% | -$28.7K | 2.37% | 15 |
|
|
2015
Q2 | $2.29M | Hold |
71,672
| – | – | 2.56% | 13 |
|
|
2015
Q1 | $2.34M | Sell |
71,672
-2,108
| -3% | -$67K | 2.6% | 12 |
|
|
2014
Q4 | $2.18M | Hold |
73,780
| – | – | 2.3% | 13 |
|
|
2014
Q3 | $2.25M | Hold |
73,780
| – | – | 2.6% | 12 |
|
|
2014
Q2 | $2.08M | Hold |
73,780
| – | – | 2.27% | 14 |
|
|
2014
Q1 | $2.25M | Hold |
73,780
| – | – | 2.6% | 12 |
|
|
2013
Q4 | $2.15M | Buy |
73,780
+5,270
| +8% | +$153K | 2.38% | 12 |
|
|
2013
Q3 | $1.84M | Hold |
68,510
| – | – | 2.5% | 12 |
|
|
2013
Q2 | $1.82M | Buy |
+68,510
| New | +$1.89M | 2.63% | 12 |
|
Other funds holding PFE
AIM
SLAM
CWP
Guardian Investment Management's PFE Position: Q2 2026 in Review
Guardian Investment Management reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $41.7K and leaving 9,417 shares worth $227K. The position accounts for 0.15% of the portfolio, ranked #59.
Guardian Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.51M in Q4 2021. 1,153 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Guardian Investment Management held 9,417 shares of Pfizer worth $227K as of Q2 2026.
- Guardian Investment Management sold 1,593 Pfizer shares in Q2 2026, an estimated $41.7K.
- Pfizer made up 0.15% of Guardian Investment Management's portfolio in Q2 2026, its #59 holding.
- Guardian Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Guardian Investment Management's Pfizer position peaked at $4.51M in Q4 2021.
- 1,153 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Guardian Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.